Katalyze AI

Katalyze is the agentic infrastructure that powers the world’s largest pharmaceutical companies.

Pharma runs on the expertise of its scientists and engineers, and too much of what they know is trapped in disconnected systems, buried in documents, locked in the heads of people who have moved on.

Katalyze closes that gap. It connects the systems a pharma operation already runs (MES, LIMS, Veeva, SAP, historians, and more than 40 connectors) into one grounded record and unified context layer, then puts expert-designed agents to work: pulling a batch's full history together, investigating deviations, reconciling records, drafting the documentation.

The agents do the assembly and the documentation. The experts keep every decision. Every answer traces to its source, built for the world's most regulated environments.

Katalyze runs in production at sites within five of the top twenty global pharma companies, where it has helped deliver more than 10 million doses, cut deviation investigations in half, and released batches 40% faster.

It was built with more than one hundred tenured scientists from companies including Sanofi, Pfizer, and Lilly, and is backed by Bonfire Ventures, Inovia Capital, Ripple Ventures, and Alumni Ventures.

Bringing a new drug to market takes more than a decade and billions of dollars. We're building to cut that in half by 2030, starting where the industry loses the most time: the operational and manufacturing arc.

We're hiring across engineering, product and GTM.